Impilo acquires VaccinDirekt – the leading Nordic retail vaccination provider
STOCKHOLM, Sweden, 16 August 2023 – Impilo has acquired VaccinDirekt from SEB Private Equity and partners with the management team to accelerate expansion of the platform.
VaccinDirekt is the largest retail vaccination provider in Sweden where it has established itself as the clear market leader, both in terms of market share and customer satisfaction. With roots back to 1972, the Company has been able to successfully lead the fast-growing retail vaccination market and has five folded the clinic network over the past five years, primarily through greenfield expansion.
“VaccinDirekt is the leading vaccination provider in a winning channel enjoying strong underlying growth, primarily driven by increased public awareness for vaccines, the enhanced focus on preventive healthcare, and a steadily growing pipeline of new vaccines. The Company is well-positioned to extend its leadership, leveraging its unparalleled quality, know-how, and customer focus, coupled with a large physical footprint in central locations, offering superior convenience and availability to its growing base of more than 1.4 million registered customers”, says Victor Steien, Partner at Impilo, and continues: “As a long-term and dedicated healthcare investor, Impilo is excited to support VaccinDirekt in driving a customer focused expansion of the platform as the Company continues to increase availability of high-quality preventive healthcare services in the Nordics”.
Headquartered in Stockholm with c. 110 FTEs and up to 600 employees in peak periods, VaccinDirekt has the broadest vaccine offering across its network of 27 walk-in clinics and 18 mobile clinics in Sweden, coupled with small but growing operations in Finland, where the Company has 5 walk-in clinics and 3 mobile clinics. The management team will remain intact following the transaction.
Toni Haapanen, CEO of VaccinDirekt, comments: “Impilo’s healthcare focus and experience make its team an ideal partner to support VaccinDirekt in this next exciting phase in the development of the Company. I am proud of what we, as a team, have achieved over the last years. With relentless focus on our customers, we have delivered strong growth and increased availability of high-quality preventive healthcare in Sweden and Finland. We are excited to continue our journey with Impilo by our side and together accelerate growth as we continue to deliver on our mission to prevent illness in everyone we meet”.
SEB Private Equity invested in VaccinDirekt in 2018 and has since then, together with management and employees, effectively transformed the Company from a local network of 5 clinics in Sweden into a leading Nordic preventive healthcare platform of 53 clinics across Sweden and Finland, resulting in annual revenue growth of c. 40%. Babak Etemad, SEB Private Equity, comments: “We are happily looking back at the impressive growth journey with VaccinDirekt. The Company is now well-positioned to continue its rapid expansion on the back of a strong- and scalable organization. We believe Impilo will make a good new home for VaccinDirekt and its employees and we look forward to continue to follow the journey ahead“.
For further information, please contact:
Toni Haapanen, CEO of VaccinDirekt, toni.haapanen@vaccindirekt.se
Victor Steien, Partner at Impilo, victor.steien@impilo.se
Babak Etemad, Investment Director at SEB Private Equity, babak.etemad@seb.se
About VaccinDirekt
VaccinDirekt is the largest retail vaccination provider in the Nordics with over 50 walk-in and mobile vaccination clinics in Sweden and Finland. With a history stemming back to 1972, VaccinDirekt‘s specially trained doctors and nurses provide high-quality services and vaccinations to more than 1.4 million satisfied customers. Learn more about VaccinDirekt at www.vaccindirekt.se/
About Impilo
Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies active in pharmaceuticals, medical technology, healthcare services, and other health-related areas. The Company strives to increase the value of its investments through long-term active ownership. Impilo has a well-diversified portfolio of investments and has raised c. SEK 10 billion in capital from leading Nordic and international investors since its inception in 2017. Learn more about Impilo at www.impilo.se/en/
About SEB Private Equity
SEB Private Equity is an active investor in privately owned companies world-wide with total capital under management of c. USD 4 billion from external institutional clients. In the Nordics, SEB Private Equity focuses on control investments in small- to midsized companies with sustainable business models and in sectors of technology and healthcare. The objective is to create long-term value through strategic and operational improvements as enabled by an active ownership model.